EW
VRTX icon

Elyxium Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Elyxium Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
657
+89
+16% +$41.5K 0.09% 132
2025
Q4 		$257K Buy
568
+46
+9% +$19.8K 0.07% 155
2025
Q3 		$204K Sell
522
-17
-3% -$7.11K 0.07% 165
2025
Q2 		$240K Buy
539
+103
+24% +$47.5K 0.09% 147
2025
Q1 		$211K Buy
+436
New +$203K 0.09% 148

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Elyxium Wealth's VRTX Position: Q1 2026 in Review

Elyxium Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 16% in Q1 2026, buying an estimated $41.5K and bringing the position to 657 shares worth $293K. The position accounts for 0.09% of the portfolio, ranked #132.

Elyxium Wealth first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Elyxium Wealth held 657 shares of Vertex Pharmaceuticals worth $293K as of Q1 2026.
  • Elyxium Wealth bought 89 Vertex Pharmaceuticals shares in Q1 2026, an estimated $41.5K.
  • Vertex Pharmaceuticals made up 0.09% of Elyxium Wealth's portfolio in Q1 2026, its #132 holding.
  • Elyxium Wealth first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.